The integrative metabolomic-transcriptomic landscape of glioblastome multiforme
Open Access
- 24 March 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (30) , 49178-49190
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Dieter Henrik Heiland1, 5, Jakob Wörner2, Jan Gerrit Haaker1, 5, Daniel Delev1, 5, Nils Pompe2, Bianca Mercas1, 5, Pamela Franco1, 5, Annette Gäbelein1, 5, Sabrina Heynckes1, 5, Dietmar Pfeifer3, 5, Stefan Weber2, Irina Mader4, 5 and Oliver Schnell1, 5 1Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany 2Institute of Physical Chemistry, Faculty of Chemistry and Pharmacy, University of Freiburg, Freiburg, Germany 3Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center, University of Freiburg, Freiburg, Germany 4Department of Neuroradiology, Medical Center, University of Freiburg, Freiburg, Germany 5Faculty of Medicine, University of Freiburg, Freiburg, Germany Correspondence to: Dieter Henrik Heiland, email: [email protected] Keywords: metabolomics, transcriptomics, network analysis, glioblastoma multiforme, WGCNA Received: January 02, 2017 Accepted: February 23, 2017 Published: March 24, 2017 ABSTRACT The purpose of this study was to map the landscape of metabolic-transcriptional alterations in glioblastoma multiforme. Omic-datasets were acquired by metabolic profiling (1D-NMR spectroscopy n=33 Patient) and transcriptomic profiling (n=48 Patients). Both datasets were analyzed by integrative network modeling. The computed model concluded in four different metabolic-transcriptomic signatures containing: oligodendrocytic differentiation, cell-cycle functions, immune response and hypoxia. These clusters were found being distinguished by individual metabolism and distinct transcriptional programs. The study highlighted the association between metabolism and hallmarks of oncogenic signaling such as cell-cycle alterations, immune escape mechanism and other cancer pathway alterations. In conclusion, this study showed the strong influence of metabolic alterations in the wide scope of oncogenic transcriptional alterations.Keywords
This publication has 44 references indexed in Scilit:
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- 1H NMR Metabolomics Analysis of Glioblastoma SubtypesJournal of Biological Chemistry, 2012
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypeNature, 2012
- Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant GliomaCA: A Cancer Journal for Clinicians, 2010
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Bevacizumab Plus Irinotecan in Recurrent Glioblastoma MultiformeJournal of Clinical Oncology, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004